IndicationsLovenox 40 mg daily subcutaneouslyLovenox 30 mg q12h subcutaneouslyHeparin 15,000 U/24h subcutaneously * Bleeding complications were considered major: (1) if the hemorrhage caused a significant clinical event, or (2) if accompanied by a hemoglobin decrease ≥2 g/dL or transfusion of 2...